Intuitive Surgical stock gains on expanded da Vinci SP use and strong Q2 figures

Published on 09/14/2026 at 14:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock is trading well below its 52-week peak despite second-quarter 2026 revenue rising 19 percent year on year, as of September 11, 2026. The shares remain pressured even as analysts highlight robust margins and procedure growth.

Börseneditorialbild mit Händlern in Businesskleidung vor großen digitalen Displays mit aufwärts gerichteten Kerzencharts des Medizintechniksektors, warmes Bernsteinlicht des Handelssaals — Intuitive Surgical US46120E6023 Börseneditorial zeigt NASDAQ Medizintechnik Wachstumschart mit Händlern im Handelssaal, Illustration mit AI erstellt.

Intuitive Surgical Inc. stock (ISIN US46120E6023) closed at USD 369.15 on the Nasdaq on September 11, 2026, leaving the minimally invasive surgery specialist well below its earlier peak even after solid second-quarter figures and a fresh regulatory milestone in Europe.

Expanded da Vinci SP indication in Europe adds to growth story

According to PR Newswire on September 14, 2026, Intuitive announced an expanded indication for its da Vinci SP single-port robotic system in Europe, widening the range of procedures that can be performed under the platform and reinforcing its position in robotic-assisted surgery.

The company described the da Vinci SP system as a key element of its portfolio aimed at enabling surgeons to carry out complex minimally invasive procedures through a single incision, and the extended European indication broadens potential utilization across hospitals already invested in the technology, as noted by EQS-News.

Second-quarter 2026 revenue climbs 19 percent year on year

As 36Kr Europe reported, Intuitive Surgical generated revenue of USD 2.892 billion in the second quarter of 2026, an increase of 19 percent compared with the same period a year earlier, underscoring continued demand for its robotic systems and related services.

According to a market overview from ad-hoc-news on September 14, 2026, instruments and accessories contributed USD 1.735 billion in second-quarter 2026 revenue, systems added USD 685 million and services brought in USD 472 million, with the latter segment rising 21 percent year on year to support a robust service-led recurring income base.

The same commentary, citing data from Tikr, noted that adjusted earnings per share reached USD 2.80 in the second quarter of 2026, ahead of consensus expectations and supported by an EBIT margin of about 42.11 percent, highlighting that profitability has remained strong even as the stock price has corrected from prior highs.

Stock trades nearly 39 percent below peak despite strong fundamentals

Per recent market data summarized by ad-hoc-news on September 14, 2026, Intuitive Surgical stock finished the Nasdaq session on September 11, 2026 at USD 369.15, roughly 39 percent below its peak near USD 610 reached in January 2025, illustrating the degree of valuation reset despite ongoing double-digit revenue growth.

The same overview indicated that, during trading on September 11, 2026, the shares moved between an intraday low near USD 362 and a high around USD 372, closing in the lower half of the day’s range and reflecting cautious investor sentiment ahead of the next earnings release even as operating performance remains solid.

According to Yahoo Finance, the consensus analyst price target for Intuitive Surgical stood around USD 476.34 with a current price quoted near USD 369.15 as of mid September 2026, implying a significant gap between prevailing market levels and average sell-side expectations.

Analyst stance and upcoming earnings date

As shown in the analyst overview on Yahoo Finance, Intuitive Surgical currently carries a consensus recommendation skewed toward Buy, with the latest recorded rating update on September 8, 2026 from BTIG, which reiterated its Buy stance and maintained a price target of USD 469, signaling continuing confidence from that analyst house despite the share-price decline.

A broader robotics and automation context presented by 24/7 Wall St on September 13, 2026 emphasized that Intuitive Surgical, used as a listed proxy for scaled robotics commercialization, was down about 34.82 percent year to date, highlighting how valuation compression across robotics and high-growth names has weighed on the stock even in the face of positive fundamental trends.

For investors monitoring upcoming catalysts, ad-hoc-news highlighted that the next scheduled quarterly earnings release for Intuitive Surgical is expected on October 20, 2026, a date that is widely viewed as a key test of whether procedure volumes and system placements can sustain the second-quarter growth trajectory.

Stock level and valuation snapshot

Intuitive Surgical stock had its most recently reported closing price at USD 369.15 on the Nasdaq on September 11, 2026, compared with a prior high near USD 610 reached in January 2025, marking a decline of close to 39 percent from that peak while the company continues to post revenue growth of 19 percent year on year in the latest quarter.